Literature DB >> 6780451

Importance of the integrity of the inter-heavy-chain disulphide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ab')2 region of rabbit IgG antibody in immune aggregates.

K J Gadd, K B Reid.   

Abstract

Immune aggregates formed from either rabbit IgG antibody or F(ab')2 antibody, and antigen, caused exactly the same extent of incubated with human serum under conditions when incubated with human serum under conditions allowing only alternative pathway activation. These observations confirm that the F(ab')2 region of the antibody molecule can cause alternative pathway activation and that this activation is not affected by the presence of the Fc region of the molecule when only alternative pathway activation is permitted. Under conditions allowing activation of both the classical and alternative pathways, increased alternative pathway activation was obtained with IgG antibody aggregates compared to that obtained with F(ab')2 antibody aggregates. On reduction and alkylation of principally he inter-heavy-chain disulphide bond in the IgG antibody, prior to aggregate formation, it was found that no activation of the alternative pathway by IgG aggregates took place under conditions allowing only alternative pathway activation. Treatment of the IgG antibody with reducing agent alone, or alkylating reagent alone, followed by dialysis and aggregate formation, yielded aggregates which caused alternative pathway activation values close to those obtained for untreated IgG aggregates. These results indicate that the integrity of the inter-heavy-chain disulphide bond of rabbit IgG antibody in immune aggregates is necessary to allow the F(ab')2 region of the IgG molecule to activate the alternative pathway of human complement.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6780451      PMCID: PMC1458207     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  The fractionation of rabbit gamma-globulin by partition chromatography.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1955-03       Impact factor: 3.857

2.  A chemical study of rabbit antiovalbumin.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1950-04       Impact factor: 3.857

3.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

4.  The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins.

Authors:  A L Sandberg; A G Osler; H S Shin; B Oliveira
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  The binding of human complement component C4 to antibody-antigen aggregates.

Authors:  R D Campbell; A W Dodds; R R Porter
Journal:  Biochem J       Date:  1980-07-01       Impact factor: 3.857

7.  The human complement system: assembly of the classical pathway C3 convertase.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1980-07-01       Impact factor: 3.857

8.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

9.  Variation in the N-terminal sequence of heavy chains of immunoglobulin G from rabbits of different allotype.

Authors:  J M Wilkinson
Journal:  Biochem J       Date:  1969-04       Impact factor: 3.857

10.  PEPSIN DIGESTION OF RABBIT AND SHEEP ANTIBODIES. THE EFFECT ON COMPLEMENT FIXATION.

Authors:  P H SCHUR; E L BECKER
Journal:  J Exp Med       Date:  1963-12-01       Impact factor: 14.307

View more
  9 in total

1.  Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.

Authors:  Azusa Hashimoto; Yusuke Suzuki; Hitoshi Suzuki; Isao Ohsawa; Rhubell Brown; Stacy Hall; Yuichi Tanaka; Jan Novak; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  Am J Pathol       Date:  2012-08-05       Impact factor: 4.307

2.  C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.

Authors:  L C Antón; J M Alcolea; P Sánchez-Corral; G Marqués; A Sánchez; F Vivanco
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

3.  Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).

Authors:  J A Schifferli; G Steiger; J P Paccaud
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

4.  The biological properties of immunoglobulin G and its split products [F(ab')2 and Fab].

Authors:  H H Sedlacek; P Gronski; T Hofstaetter; E J Kanzy; H U Schorlemmer; F R Seiler
Journal:  Klin Wochenschr       Date:  1983-08-01

Review 5.  The role of antibody in the activation of the alternative complement pathway.

Authors:  W D Ratnoff; D T Fearon; K F Austen
Journal:  Springer Semin Immunopathol       Date:  1983

6.  The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.

Authors:  K J Gadd; K B Reid
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

7.  Complement activation by phospholipids: the interplay of factor H and C1q.

Authors:  Lee Aun Tan; Bingbin Yu; Francis C J Sim; Uday Kishore; Robert B Sim
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

8.  The complement system of the goat: haemolytic assays and isolation of major proteins.

Authors:  Isabel Moreno-Indias; Alister W Dodds; Anastasio Argüello; Noemi Castro; Robert B Sim
Journal:  BMC Vet Res       Date:  2012-06-26       Impact factor: 2.741

Review 9.  How immune complexes from certain IgG NAbs and any F(ab')₂ can mediate excessive complement activation.

Authors:  Hans U Lutz
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.